Company Search:
Advanced Search
Sponsored Links
Onxeo SA Company Snapshot
Onxeo SA operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Onxeo SA with three other pharmaceutical manufacturers in Europe: 4Sc AG of Germany (2015 sales of 3.27 million Euro [US$3.59 million] of which 70% was Drug Discovery & Development), Nattopharma ASA of Norway (31.69 million Norwegian Kroner [US$3.89 million] of which 100% was Vitamin K2/MenaQ7), and Santhera Pharmaceuticals Holding AG which is based in Switzerland (4.32 million Swiss Francs [US$4.36 million] of which 100% was Pharmaceutical Products).

Sales Analysis. Sales fell dramatically in 2015: Onxeo SA reported sales of 3.48 million Euro (US$3.82 million) for the year ending December of 2015. This represents a sharp decrease of 84.2% versus 2014, when the company's sales were 22.08 million Euro. Contributing to the drop in overall sales was the 85.4% decline in Other, from 2.99 million Euro to 436,000.00 Euro. There were also decreases in sales in Orphan Products Oncology (down 84.0% to 3.05 million Euro) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Onxeo SA
  Stock Performance Chart for Onxeo SA
  Stock Data: Recent Stock Performance:
  Current Price (10/14/2016): 2.53
(Figures in Euro)
1 Week -1.9%   13 Weeks -17.9%  
4 Weeks -20.9%   52 Weeks -31.4%  
Onxeo SA Key Data:
  Ticker: ONXEO Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 3,481,000
(Year Ending Jan 2016).
Employees: 48
  Currency: Euro Market Cap: 104,838,021
  Fiscal Yr Ends: December Shares Outstanding: 41,437,953
  Share Type: Action Ordinaries Closely Held Shares: 5,824,262
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.